Verition Fund Management LLC Bio Xcel Therapeutics, Inc. Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$1.14 - $2.97 $28,676 - $74,710
25,155 New
25,155 $32,000
Q1 2023

May 15, 2023
BUY
$17.7 - $33.24 $235,728 - $442,690
13,318 New
13,318 $248,000
Q1 2020

May 15, 2020
SELL
$12.26 - $41.14 $208,370 - $699,215
-16,996 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$4.05 - $14.61 $68,833 - $248,311
16,996 New
16,996 $248,000

Others Institutions Holding BTAI

# of Institutions
55
Shares Held
3.14M
Call Options Held
22.2K
Put Options Held
40.2K
View Full List

About BioXcel Therapeutics, Inc.

BTAI Quotes by TradingView
  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $14.3M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email